Influence of human serum on antifungal pharmacodynamics with Candida albicans (Q39477738)

12 September 2017

Influence of human serum on antifungal pharmacodynamics with Candida albicans (English)

1 reference

12 September 2017

1 reference

1 reference

G G Zhanel

1

1 reference

12 September 2017

D G Saunders

series ordinal

2

1 reference

12 September 2017

D J Hoban

series ordinal

3

1 reference

12 September 2017

J A Karlowsky

series ordinal

4

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Antimicrobial Agents and Chemotherapy

12 September 2017

1 reference

12 September 2017

45

1 reference

12 September 2017

7

1 reference

12 September 2017

2018-2022

1 reference

Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90594

Influence of human serum on pharmacodynamic properties of an investigational glycopeptide, LY333328, and comparator agents against Staphylococcus aureus

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90594

Pharmacodynamics of fluconazole in a murine model of systemic candidiasis.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90594

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90594

In vitro kill curves of a new semisynthetic echinocandin, LY-303366, against fluconazole-sensitive and -resistant Candida species

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90594

Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90594

In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90594

Antibiotic activity in microbiological media versus that in human urine: comparison of ampicillin, ciprofloxacin, and trimethoprim-sulfamethoxazole

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90594

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90594

Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90594

Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90594

Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90594

Candidemia in a Canadian tertiary care hospital from 1976 to 1996.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90594

Antifungal susceptibility testing: technical advances and potential clinical applications.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90594

Pharmacokinetics and pharmacodynamics of outpatient intravenous antimicrobial therapy

15 June 2018

1 reference

12 December 2020

Influence of serum protein binding on the in vitro activity of anti-fungal agents

1 reference

12 December 2020

Influence of human serum on the postantifungal effect of four antifungal agents on Candida albicans

1 reference

12 December 2020

Effects of sublethal concentrations of amphotericin B on Candida albicans

1 reference

12 December 2020

10.1128/AAC.45.7.2018-2022.2001

Identifiers

DOI

1 reference

12 September 2017

1 reference

12 September 2017

1 reference